—

Takeda Pharmaceutical Co Ltd ADR(TAK)— 同类公司组

数据截至2026-10-14 — 评分每个交易日晚间重新计算。分组标准=首先为共同的Closelook指数成分,其次为行业。Closelook研究日记,不构成投资建议。

Takeda Pharmaceutical Co Ltd ADR的Closelook综合评分为51/100,在同类公司组内排名第11位(共11家)——组内评分最高的是Halozyme Therapeutics Inc(74/100)。

名称综合动量质量估值信号距52周高点
TAK Takeda Pharmaceutical Co Ltd ADR51743879ok0.5%
ROVI.MC Laboratorios Farmaceuticos ROVI61297749info30.7%
LNTH Lantheus Holdings Inc60697353info10.6%
KNSA Kiniksa Pharmaceuticals Ltd56945718ok4.9%
BHC.TO Bausch Health Companies Inc55657082info24.2%
GALDY GALDERMA GROUP AG55525825info11.4%
FAGR.BR Fagron NV53435559info11.1%
HALO Halozyme Therapeutics Inc74979447ok2%
DXCM DexCom Inc65818034bull8.1%
ARGX argenx NV ADR61507427info23.7%
HQY HealthEquity Inc61566942info16.5%

评分为Closelook全部覆盖范围内的相对读数——方法论见公司评分说明。信号灯来自每日夜间信号看板。

FAQ · from the current data · as of 2026-10-14

Quick answers

Takeda Pharmaceutical Co Ltd ADR在Closelook覆盖范围内的同类公司有哪些?

分组首先基于共同的Closelook指数成分,其次基于行业:Laboratorios Farmaceuticos ROVI (ROVI.MC)、Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Bausch Health Companies Inc (BHC.TO)、GALDERMA GROUP AG (GALDY)、Fagron NV (FAGR.BR)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

TAK相对同类公司的评分如何?

Takeda Pharmaceutical Co Ltd ADR的综合评分为51/100,组内排名第11位(共11家),截至2026-10-14;组内最高综合评分为Halozyme Therapeutics Inc(74/100)。Closelook评分为研究日记读数,不构成评级或投资建议。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.